MICARDIS -----------------------WARNINGS AND …
Control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management,
Download MICARDIS -----------------------WARNINGS AND …
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Advertisement
Documents from same domain
HIGHLIGHTS OF PRESCRIBING INFORMATION o …
docs.boehringer-ingelheim.comHIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use PRADAXA safely and effectively. See full prescribing information for
Information, Highlights, Prescribing, Prescribing information, Highlights of prescribing information
MEDICATION GUIDE PRADAXA (pra dax a) …
docs.boehringer-ingelheim.com(dabigatran etexilate mesylate) capsules Read this Medication Guide before you start taking PRADAXA and each time you get a refill. There may be new
DOSAGE FORMS AND STRENGTHS------------------ …
docs.boehringer-ingelheim.comPage 2 of 28 FULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE 1.1 Parkinson's Disease MIRAPEX tablets are indicated for the treatment of …
HIGHLIGHTS OF PRESCRIBING INFORMATION ...
docs.boehringer-ingelheim.comFULL PRESCRIBING INFORMATION WARNING: ASTHMA-RELATED DEATH Long-acting beta2-adrenergic agonists (LABA) such as olodaterol, one of the active ingredients in STIOLTO RESPIMAT, increase the risk of asthma-related
HIGHLIGHTS OF PRESCRIBING INFORMATION …
docs.boehringer-ingelheim.com2 FULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE OFEV is indicated for the treatment of idiopathic pulmonary fibrosis (IPF). 2 DOSAGE AND ADMINISTRATION
HIGHLIGHTS OF PRESCRIBING INFORMATION …
docs.boehringer-ingelheim.comHIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use SPIRIVA HANDIHALER safely and effectively.
Prescribing Information - docs.boehringer …
docs.boehringer-ingelheim.comHIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use SPIRIVA RESPIMAT safely and effectively.
HIGHLIGHTS OF PRESCRIBING INFORMATION …
docs.boehringer-ingelheim.comFULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE 1.1 EGFR Mutation-Positive, Metastatic Non-Small Cell Lung Cancer GILOTRIF is indicated for the first-line treatment of patients with metastatic non-small cell lung cancer
HIGHLIGHTS OF PRESCRIBING INFORMATION Before initiating ...
docs.boehringer-ingelheim.com3 for volume contraction and correct volume status if indicated. Monitor for signs and symptoms of hypotension after initiating therapy and increase monitoring in clinical situations where volume contraction is expected [see Use in Specific Populations (8.5)].
PredniSONE Tablets USP, 1 mg, 2.5 mg, 5 mg, 10 mg, 20 mg ...
docs.boehringer-ingelheim.comacute nonspecific tenosynovitis, acute gouty arthritis, post-traumatic osteoarthritis, synovitis of osteoarthritis, epicondylitis. ... Increased dosage of rapidly acting corticosteroids is indicated in patients on corticosteroid therapy subjected to any unusual stress before, during and after the stressful situation.
Related documents
M.I. Arterial Hypertension December 2011
www.antidoping.skMedical Information to Support the Decisions of TUECs Arterial Hypertension © WADA- World Anti-Doping Program Version 2.0 December 2011 1 Arterial Hypertension
DRUG NAME: SUNItinib - BC Cancer
www.bccancer.bc.caSUNItinib DRUG NAME: SUNItinib SYNONYM(S): SU11248, 1 SUNItinib malate 2 COMMON TRADE NAME(S): SUTENT® CLASSIFICATION: tyrosine kinase inhibitor Special pediatric considerations are noted when …
Plendil ER Data Sheet 280218 - Medsafe Home Page
www.medsafe.govt.nzPlendil ER Data Sheet 280218 Copyright Doc ID-003841439 v1 7 left ventricular function, as assessed by ejection fraction or stroke volume, and does